R ight ventricular (RV) pump function is of essential clinical and prognostic importance in a variety of heart and lung diseases and in pulmonary arterial hypertension (PAH). [1] [2] [3] [4] [5] Survival in pulmonary hypertension (PH) patients depends on the capability of the RV to adapt to chronically elevated pulmonary artery pressures. 6 Therefore, an accurate evaluation of RV pump function is crucial for screening, diagnosis, and follow-up assessment in PH. 7 However, it is difficult to assess RV function because of its complex geometry and load dependence and because of inadequate standardization of the assessment. 8 This is true for both noninvasive and invasive techniques.
reserve refers to changes in systolic function 11 and has not been assessed in patients with PAH or inoperable chronic thromboembolic PH (CTEPH). In small studies, RV contractile reserve has been estimated during dobutamine stress echocardiography and had a prognostic impact in patients with mitral valve disease using RV tissue Doppler indexes (isovolumic contraction) 12 and in left heart failure using plots with RV pressurearea relations, 1 but there are no established methods to assess RV contractile reserve. 11 Exercise-induced changes in radionuclide RV ejection fraction seemed to be inversely related to pulmonary artery pressure changes in patients with valvular left heart disease. 3 The objectives of this study were to prospectively assess exercise-induced increase in pulmonary arterial systolic pressure (PASP) as a possible measure of the RV contractile reserve using exercise stress echocardiography in patients with invasively confirmed manifest PH and to analyze the prognostic impact of exercise-induced PASP increase in context with other prognostically relevant parameters.
Methods

Study Population and Design
This prospective study investigated patients with severe chronic PAH or inoperable CTEPH and right heart failure, World Health Organization functional class II to IV. For safety reasons, only patients between 18 and 80 years of age and those who received an optimized medical PAH-targeted therapy (eg, endothelin antagonists, inhaled or parenteral prostanoids, phosphodiesterase inhibitors, anticoagulants, diuretics, and supplemental oxygen) for at least 2 months before entering the study were included. Patients had to be able to participate in standard echocardiography and cardiopulmonary exercise testing. The maximal PASP value during exercise was obtained as mean value of at least 3 measurements. To avoid the inclusion of patients with only mild impairment of RV pump function and to make both groups comparable, patients with a workload of >75 W during stress Doppler echocardiography were excluded. Thus, the PASP increase has been compared in low workloads only. Patients were then assigned to a high or low PASP increase group according to the median of the obtained maximal increase in PASP reached during exercise.
The diagnosis was established at the participating PH centers according to current guidelines. 7, 9 All patients underwent a detailed clinical workup, including medical history, physical examination, ECG, 2-dimensional echocardiography at rest and during exercise, lung function test, arterial blood gases, cardiopulmonary exercise testing, 6-minute walking distance (6MWD) under standardized conditions, 13 quality-of-life questionnaire (Short Form-36) and laboratory testing, including N-terminal pro-brain natriuretic peptide (NT-proBNP) levels. All tests were performed in Heidelberg and set as the baseline assessment. Left heart catheterization or computed tomography of the lungs was performed in all patients with suspected left heart or respiratory diseases and when clinically indicated. Exercise-induced PASP and peak Vo 2 were assessed by an experienced team at the Thoraxclinic in Heidelberg in all patients. Because this study was exploratory, no power analysis or sample size estimate was performed in advance. All patients gave written informed consent for this study, which was approved by the Ethics Committee of the University of Heidelberg.
Echocardiography
Two-dimensional and color flow-guided continuous-wave Doppler echocardiographic recordings were obtained by experienced cardiac sonographers (E.G., C.N.) using 2.5-MHz Duplex probes and conventional equipment (Vivid 7, GE Healthcare, Milwaukee, WI) on 2 occasions: at rest and during stress as described previously.
14 PASP was estimated from peak tricuspid regurgitation jet velocities (TRVs) according to the following equation: PASP= 4(V) 2 +right atrial pressure, where V is the peak velocity (in m/s) of tricuspid regurgitation jet (TRV). 15 For all calculations, the mean value of at least 3 TRV measurements was used. As in patients with atrial fibrillation, there is a high beat-to-beat variation; therefore, the mean value of 5 measurements at different beats was used to estimate each PASP value. Right atrial pressure was estimated from characteristics of the inferior vena cava. 16 If it was <20 mm in diameter and decreased during inspiration, we added 5 mm Hg; if it was ≥20 mm, we added 10 mm Hg; and if no decrease in diameter during inspiration occurred, we added 15 mm Hg. Echocardiographic assessments were performed according to current guidelines. 8 
Stress Doppler Echocardiography and Cardiopulmonary Exercise Testing
Patients were examined on a variable-load supine bicycle ergometer (model 8420; KHL Corp, Kirkland, WA) in Heidelberg as described previously.
14 Workload was increased by 25 W every 2 minutes to an exercise capacity or symptom-limited maximum. TRV, heart rate, oxygen saturation, and systemic blood pressure were analyzed at each stage. Echocardiographic assessment was stored in DICOM (digital imaging and communications in medicine) format. The anaerobic threshold was determined from the V-slope method. 17 Peak Vo 2 was defined as the highest 30-second average value of oxygen uptake during the last minute of the exercise test. The Borg dyspnea index (with 6 representing no exertion and 20 representing maximal exertion) 18 was assessed immediately after the test.
Follow-Up Assessment
In 2012, all participating patients were interviewed either by phone or at a control visit in the Thoraxclinic Heidelberg to evaluate symptoms, World Health Organization functional classification, current medication, and any cardiopulmonary events that might have occurred since last observation. Furthermore, medical records were reviewed to document, among others, potential worsening events and current medication. If the patient was deceased, date of death was recorded, and treating physicians or relatives were asked for the cause and circumstances of death. The PASP increase during exercise, cardiopulmonary exercise parameters, echocardiographic parameters, and 6MWD were analyzed for their predictive value on survival.
Statistical Methods
Statistical analyses were conducted by a statistician (C.F.). Data are described as mean±SD. For follow-up assessments, baseline was defined as the day the patient underwent the cardiopulmonary exercise test. Survival time was estimated from baseline until June 2012 (end of follow-up in this study). All quantitative characteristics between the 2 groups at baseline and during follow-up were compared by t tests or Mann-Whitney U tests. For comparison of categorical variables between groups, the χ 2 test was used. In case of larger tables, the Craddock-Flood and Haldane-Dawson tests were used. The Craddock-Flood test is recommended for large tables with small degrees of freedom and low-frequency cells, whereas the HaldaneDawson test is used for contingency tables with >5 rows or columns and small sample sizes. 19, 20 For analysis of survival, death was the end point. One case of lung transplantation was added to the deaths.
No patient died of noncardiopulmonary causes. Three patients were lost to follow-up and are described but were not included in the survival analysis.
For analysis of predictive parameters for probability of death, we performed univariate and multivariate analyses. For all quantitative variables, we used the median value to divide the cohort into 2 groups, and we used the dichotomous variables for analysis of their influence on survival. The univariate analyses were performed with log-rank tests for comparing the Kaplan-Meier survival curves. 21 All variables identified with the univariate log-rank tests as being significantly associated with survival (P<0.05) were analyzed further with a multivariate Cox model for each parameter adjusted for the potential confounders of age and sex. The 2 variables with the highest significance were included in the final Cox model estimation including confounders of age and sex. Effect sizes are given as hazard ratio point estimates with 95% confidence intervals within Cox proportional hazard model. 22 For univariate and multivariate analyses, we performed a sensitivity analysis including only patients with PAH. All analyses were performed with IBM SPSS 20 (SPSS Statistics version 20, IBM Corp, Somers, NY).
Results
Study Population
We prospectively included 153 patients diagnosed with severe PH and right heart failure; 7 patients were excluded because TRV could not be obtained during exercise, and 21 patients were excluded because they reached workloads >75 W during stress Doppler echocardiography, suggesting only mildly impaired RV pump function (Table 1) . Thus, the final study group consisted of 124 patients with invasively confirmed manifest PH and severely impaired RV pump function (37 men and 87 women; mean age, 54±16 years; 104 with PAH and 20 with inoperable CTEPH; Table 1 and Figure 1 ). The exclusion of the 21 patients who reached higher workloads made the assessment of PASP increase during exercise more comparable between groups and did not significantly change the results of univariate and multivariate analyses or the estimated survival rates.
Subgroups With Different Exercise-Induced PASP Increases Suggesting Different RV Contractile Reserve
According to the median exercise-induced PASP increase of 30 mm Hg, we defined 2 subgroups: Group A with low PASP (PASP ≤30 mm Hg, suggesting reduced or low RV contractile reserve) included 66 patients (24 men and 42 women; mean age, 57±15 years), and group B with high PASP (PASP >30 mm Hg, suggesting preserved RV contractile reserve) included 58 patients (13 men and 45 women; mean age, 50±17 years; Table 1 ).
Both groups did not differ significantly in terms of their hemodynamic values measured by right heart catheterization or targeted PAH medication at baseline (Tables 1 and 2 ). According to right heart catheterization, at rest, both groups had markedly reduced cardiac output and cardiac index and elevated pulmonary vascular resistance and mean pulmonary arterial pressures (Table 1) . Echocardiography showed markedly enlarged RV area, reduced tricuspid annular plane systolic excursion, and severely elevated LV eccentricity index resulting from compressed LV by the enlarged RV (Table 2) . LV ejection fraction did not differ significantly between groups (PASP increase <30 mm Hg, 82.6±16.8%; PASP increase >30 mm Hg, 85.8±17.7%; P=0.356). Patients with impaired LV function/PH resulting from left heart disease were not included in the study. In both subgroups, 4 patients with atrial fibrillation were included. Group A patients were older (P=0.018) and had higher mean NT-proBNP levels (P=0.006), mean heart rate at rest (P=0.033), and mean right atrial area (P=0.011) compared with group B patients. Except for these resting parameters, the patients of both subgroups did not differ significantly in terms of right heart catheterization and echocardiography measures (Table 1) . Patients with high PASP response (group B) had similar echocardiographic findings at rest with severely enlarged RV compared with patients in group A (Figure 2 
Clinical and Technical Observations During Exercise Stress Echocardiography
In almost all patients, TRV could be assessed by echocardiography at rest and during exercise owing to the presence of tricuspid regurgitation in the enlarged right hearts. Stress echocardiography and cardiopulmonary exercise testing were safe and could be performed without complications in all patients.
Correlation of Peak Vo 2 per Kilogram and 6MWD in Groups With Low and High Exercise-Induced PASP Increase
There were significant but weak correlations of the PASP increase during exercise with 6MWD and peak Vo 2 per kilogram ( Figure 3A and 3B). Patients with high exercise-induced PASP increase also showed higher values for peak Vo 2 per kilogram and 6MWD compared with patients with a low PASP increase.
Follow-Up and Survival Analyses
During a mean follow-up period of 3.0±1.8 years (median, 2.9 years; interquartile range, 2.0-3.9 years), 31 patients died as a result of PH or right heart failure, and 3 patients were lost to follow-up ( Figure 4A and 4B). During the follow-up, significantly more patients died in group A compared with group B (24 versus 7 patients). Patients in group A revealed significantly lower 1-, 3-, and 4-year survival rates of 92%, Illustration of the entire study from the enrollment process until the end of follow-up. CTEPH indicates chronic thromboembolic pulmonary hypertension; PAH, pulmonary arterial hypertension; PASP, pulmonary arterial systolic pressure; and PH, pulmonary hypertension.
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Prognostic Factors in the Univariate and Multivariate Analyses
Clinical parameters were analyzed with univariate and multivariate methods. Table 3 shows the results of the univariate log-rank test and the multivariate Cox model analyses. Hazard ratios define the ratio of death probability. The value for increased death probability is given in Table 3 . In values available in >95% of the patients, the following parameters remained predictive for survival with P<0.05 after adjustment for sex and age: 6MWD, peak Vo 2 , peak Vo 2 per kilogram, peak PASP, and ΔPASP (Table 3) .
The ability to increase PASP >30 mm Hg during exercise was predictive of survival and had the highest hazard ratio (3.15 adjusted Cox model estimation) of all variables. Because peak Vo 2 per kilogram is a validated prognostic factor, we wanted to know whether ΔPASP is an additional independent factor for survival in our data. We found that the adjusted multivariate Cox model with ΔPASP and peak Vo 2 per kilogram shows a significant improvement compared with the Cox model with peak Vo 2 per kilogram (χ 2 =5.56; P=0.018). Therefore, peak Vo 2 per kilogram and PASP increase during exercise remained independent predictors of survival (Table 3 and Figure 5 ). Patients who were positive for both independent risk factors at baseline (peak Vo 2 per kilogram ≤11.4 mL·min −1 ·kg −1 and exercise-induced PASP-increase ≤30 mm Hg) had the worst survival rate of 84%, 54%, and 42% at 1, 3, and 4 years, respectively ( Figure 5) . In contrast, patients ·kg −1 had a 3-year survival rate of 97% ( Figure 5 ).
In patients with and without pericardial effusion, the total death rate was 25%. Thus, in the univariate analysis, pericardial effusion was not a significant prognostic factor (P=0.745). Distribution of patients with pericardial effusion in the 2 subgroups (PASP increase >30 and <30 mm Hg) was similar with 8 patients in each group (12.1% versus 13.8%).
Sensitivity analysis excluding patients with CTEPH led to similar results with a median value of PASP increase of 30 mm Hg and significant results for univariate and multivariate analyses. The multivariate analysis for the cohort excluding CTEPH patients defines peak Vo 2 >11.45 mL·min −1 ·kg −1 (hazard ratio, 4.63), peak oxygen saturation >89% (hazard ratio, 3.66), and PASP increase during exercise >30 mm Hg (hazard ratio, 3.31) to be of higher probability of death.
Discussion
This is the first study to evaluate exercise-induced PASP increase using stress echocardiography in a large cohort of patients with severe PAH or inoperable CTEPH and right heart failure. The group of patients who revealed a high exercise-induced PASP increase, that is, a response above the median value of 30 mm Hg, had a significantly higher mean 6MWD and mean peak Vo 2 per kilogram; lower mean heart rate, NT-proBNP, and right atrial area; and better 1-, 3,-and 4-year survival rates. The study revealed that PASP increase during low-workload exercise assessed by echocardiography is an independent prognostic factor. Exercise-induced PASP increase could be an estimate of RV contractile reserve. Therefore, stress echocardiography may be instrumental for follow-up assessment especially for identifying PH patients at high risk of mortality.
Measurements of Contractile Reserve in Heart Failure
Contractile reserve of the RV and LV has been defined by the change in ejection fraction or stroke volume during exercise or dopamine/norepinephrine infusion. 10, 11 An increase in LV and RV radionuclide ejection fraction ≥5% during exercise was found in healthy volunteers, with significantly higher levels of LV ejection fraction increase in men compared with women (10.5% versus 5.3%). 23 LV contractile reserve has been shown to be a strong prognostic predictor in patients with left heart failure caused by idiopathic dilated cardiomyopathy, [24] [25] [26] [27] [28] valvular heart disease, 12, 29 and coronary artery disease. 30, 31 There are few data on RV contractile reserve and no standardized methods for how to measure it. LV contractile reserve has been estimated by invasively 30, 32 or noninvasively measured changes in LV ejection fraction, 33 radionuclide stroke volume, 26 and cardiac power (aortic pressure times aortic flow) 25 or by echocardiographic parameters of LV function, including wall thickness. 27, 28 There have been no studies on RV contractile reserve in patients with right heart failure caused by PAH or CTEPH. The concept of estimating RV contractile reserve by PASP increase during exercise has not previously been applied to PH patients. Patients with severe tricuspid regurgitation have Figure 2 . Illustration of 2 groups with low (group A) and high (group B) pulmonary arterial systolic pressure (PASP; also sPAP) increase during exercise. PASP changes that occur during cardiopulmonary exercise testing among pulmonary hypertension patients with medium to severe impairment of right ventricular pump function. In some of the patients, a significant increase in PASP can be observed during exercise, whereas in others, the change is minimal, although echocardiographic parameters such as right heart size were not significantly different. not been included in this patient cohort. However, it has to be noted that measurement of PASP increase during exercise is limited in patients with severe tricuspid regurgitation because estimates of PASP (and RV cardiac output) are less accurate. Furthermore, in patients with atrial fibrillation, the accuracy of the estimation of PASP values could be limited by a high beat-to-beat variation.
Rationale for Choosing Exercise-Induced PASP Increase to Estimate RV Contractile Reserve
Exercise-induced PASP increase has been shown to be closely related to RV function. The ability of the RV to increase pressure depends on the maintenance of RV arterial coupling 34 and the ability to maintain or increase stroke volume during exercise without dilating. 35 Janicki et al 36 have shown that the exercise-induced pulmonary arterial pressure-flow relationship in PH is very steep. Thus, a large increase in PASP implies the capacity of the RV to eject a large stroke volume despite high pressures reflecting a preserved RV contractile reserve. In our study, patients in groups A and B had similar workloads and no pulmonary stenosis. The slightly lower heart rate at rest in group B with a better PASP increase reflects most likely the better contractile reserve. The lower peak heart rate during exercise in the group with inadequate PASP increase may reflect a slightly lower level of stress. It might also reflect a higher proportion of patients with chronotropic insufficiency, which is a common symptom in patients with PH. Both patient groups did not differ in their respiratory quotient, which also indicates a similar exercise capacity. Most patients with severely impaired RV pump function reached workloads <75 W in the symptom-limited supine exercise test. We excluded patients with higher workloads to obtain comparable results between the 2 groups and to avoid the possibility that different PASP responses to exercise are attributable to different levels of stress. Thus, differences in PASP increase during exercise most likely represented different abilities of the RV to increase cardiac output and could therefore be used to assess the contractile reserve of the RV. For further hemodynamic assessment or proof of RV contractile reserve, it would be useful to perform follow-up assessments using right heart catheterization not only at rest but also during exercise. However, this will be not suitable in every patient and is even more dangerous than the noninvasive parameters.
Besides the physiological rationale for choosing exerciseinduced PASP increase for estimation of RV contractile reserve, there are technical advantages. Estimation of PASP by echocardiography is easier and more precise than the echocardiographic assessments of RV ejection fraction or cardiac output during exercise. Both parameters can be estimated by pulsed Doppler velocity-time integral measurements, but they are difficult to measure even at rest and are not very reliable. 37 The assessment becomes even more demanding during exercise, especially in PH patients with an enlarged RV and complex geometry. Because of the high intraobserver and interobserver variabilities, it would be difficult to establish these methods for routine follow-up in PH patients. In contrast, the measurement of TRV by means of stress Doppler echocardiography and cardiopulmonary exercise testing is much easier and more accurate in patients with manifest PH and enlarged RV, although this technique had many pitfalls in the screening for PH. 38 Nearly all patients with PH and enlarged RV have at least mild tricuspid regurgitation. Therefore, we were able to obtain the PASP increase in ≈95% of our patients with clear-shaped Doppler profiles.
Stress Echocardiography in Manifest PH
The assessment during exercise with low workloads (50-75 W) remained without complications, although all patients had a severely impaired RV pump function and severe PAH/ CTEPH. As the cutoff value for a high or low PASP increase, we used the median value of 30 mm Hg. In healthy subjects, normal PASP increase during low-dose exercise (within 75 W on a supine bicycle ergometer test) was ≈10 mm Hg (from 20.4±5.3 to 29.8±5 mm Hg, an ≈46% increase). 14 In the PH patient cohort, mean PASP at baseline was 70 mm Hg, and an increase >30 mm Hg corresponds to a 45% increase. However, the true cutoff value obviously cannot be obtained in healthy control subjects. It may even be more useful to perform echocardiography together with cardiopulmonary exercise testing. Peak Vo 2 per kilogram and PASP increase were the only independent prognostic predictors, and a very poor prognosis was indicated if both parameters were reduced. Other signs of a severely reduced RV contractile reserve during stress Doppler echocardiography such as the insufficient increase or even drop of systemic pressures should also be considered. 39 Today, the only indication listed in international guidelines for evaluating PASP during exercise by stress echocardiography is in symptomatic patients with mild mitral valve stenosis or insufficiency. In these patients, percutaneous valvotomy or valve surgery may be performed if the PASP during exercise exceeds 60 mm Hg. 40 In patients with left heart failure or with significant mitral regurgitation, PASP increase during exercise has a different pathophysiology, reflects an increase in left atrial pressure and impaired LV diastolic reserve, and is a predictor of poorer prognosis. 41 
Prognostic Parameters
So far, hemodynamic variables at baseline (eg, elevated mean right atrial pressure, mean pulmonary artery pressure, and reduced cardiac index) have shown to be prognostic predictors. 4, 39, 42, 43 From these parameters, an equation to predict a patient's likelihood of survival has been created. 4 However, this equation is based on patients with idiopathic and heritable Log-rank test P values, continuous variables were classified in low ≤ median and high > median. HRs and their 95% CIs were estimated with log-rank tests and Cox regression models including age and sex as confounders, showing the probability of death. The value with higher probability of death is defined in parentheses after the variable. CI indicates confidence interval; HR, hazard ratio; NT-proBNP, N-terminal pro-brain natriuretic peptide; PASP, pulmonary arterial systolic pressure; 6MWD, 6-minute walking distance; TAPSE, tricuspid annular plane systolic excursion; Vo 2 /kg, maximum oxygen consumption per kilogram; and WHO, World Health Organization.
by guest on June 6, 2017 http://circ.ahajournals.org/ Downloaded from PAH before PAH-targeted medication was available; therefore, it may not reflect the wider PAH population in the modern treatment era. 44 In addition to baseline hemodynamic parameters, the New York Heart Association functional class, 45 heart rate, 46 6MWD, 47, 48 echocardiographic predictors 49 such as pericardial effusion, NT-proBNP, 50 and platelet level 51 have been found to correlate with the prognosis in PH patients. 43, 44 Peak oxygen uptake and peak systolic blood pressure during cardiopulmonary exercise testing were also shown to be of major prognostic value in patients with idiopathic PAH. 52 Recently, Nickel et al 53 described changes in World Health Organization functional class, cardiac index, mixed venous oxygen saturation, and NT-proBNP during follow-up visits as significant predictors of outcome. The noninvasive estimation of PASP increase during exercise described here has been obtained in patients who were on optimized PAH-targeted treatment and may therefore also be useful in follow-up assessments of patients. Most recent findings confirmed that the RV pump function is a stronger predictor for prognosis than baseline pulmonary vascular resistance and may decrease despite a reduced pulmonary vascular resistance by PAH-targeted medical therapies. 35 The results of our study may add to this finding that the assessment of PASP increase during exercise as an estimate for RV contractile reserve may be even more important than the resting hemodynamics for the follow-up and therapeutic management of PH patients. Patients with high PASP increase and peak oxygen consumption >11.4 mL·min −1 ·kg −1 had good long-term survival and probably do not need an increase in treatment, although they might have severely impaired resting hemodynamics. In contrast, patients with reduced PASP increase during exercise and peak oxygen consumption might need escalation of PAH medication or may even need to be listed for lung transplantation. Both patient groups could be hardly distinguished by resting hemodynamics and clinical parameters alone. Estimation of RV contractile reserve may be even more important than resting hemodynamics measured by echocardiography for the follow-up and therapeutic management of PH patients. In contrast, patients with reduced PASP increase during exercise and peak oxygen consumption might be further evaluated if an escalation of PAH medication is necessary.
In this study, patients with moderate to severe impairment of RV function, mostly World Health Organization functional class III to IV, were included. PASP increase during exercise might also be a feasible parameter in patients with less severe PH. Further studies are needed to investigate the effect on patients with less severe disease and in predefined workloads, for example, 50 W, or workloads adjusted to the patients' body weight. The biology of RV contractility in PAH is not known. Therefore, we used a common strategy of dividing the sample by the median value, which therefore depends on the sample. The cut point and the effect size have to be validated in other samples.
Clinical Implications and Conclusions
Assessment of PASP increase during exercise by stress echocardiography at low workloads may reflect RV contractile reserve and can contribute to follow-up assessment and risk stratification of PAH/CTEPH patients. The combination of stress Doppler echocardiography and cardiopulmonary exercise test revealed the most important independent prognostic factors to be peak Vo 2 and low PASP increase and may be useful for therapeutic decision making by identifying patients of especially high risk and inadequate therapy. Estimation of RV contractile reserve may be even more important than resting hemodynamics measured by echocardiography for the followup and therapeutic management of PH patients.
